SPECIFICITY OF ANTICOAGULANT CHOICE FOR VTE PROPHYLAXES AFTER MAJOR ORTHOPEDIC SURGERY- THE VIEW OF CLINICAL PHARMACOLOGISTS

Cover Page


Cite item

Abstract

The issue of development of venous thrombosis and embolism still remains a serious problem in the traumatology and orthopedics. To maintain a balance between efficacy of thromboprophylaxis and the risk of serious bleeding in special patient groups the authors encourage to undertake the choice of anticoagulant on an individual basis taking into account the patient's weight, as his liver and kidneys, the duration of prophylaxis course, the possibility of laboratory monitoring of coagulation parameters after discharge from hospital. The authors analyze the possibility of the use of new oral anticoagulants in patients after hip or knee arthroplasty.

About the authors

S. A. Bozhkova

ФГУ «Российский научно-исследовательский институт травматологии
и ортопедии им. Р.Р. Вредена» Минздравсоцразвития России

Author for correspondence.
Email: clinpharm-rniito@yandex.ru
к.м.н., заведующая отделением клинической фармакологии Russian Federation

References

  1. Протокол ведения больных. Профилактика тромбоэмболии легочной артерии при хирургических и иных инвазивных вмешательствах (ОСТ 91500.11.0007-2003). – М. : НЬЮДИАМЕД, 2004. – 64 с.
  2. Российские клинические рекомендации по диагностике, лечению и профилактике венозных тромбоэмболических осложнений // Флебология. – 2010. – №1, вып. 2. – С. 3–37.
  3. Camporese, G. Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial / G. Camporese [et al.] // Ann. Intern. Med. – 2008. – Vol. 149, N 2. – P.73–82.
  4. Dahl, O.E. Efficacy and safety profile of dabigatran etexilate compared with enoxaparin in primary venous thromboembolism prevention after total knee or hip replacement surgery in patients over 75 years / O.E. Dahl [et al.] // Blood. – 2008. – Vol. 112. – P. 167
  5. Dahl, O.E. Efficacy and safety profile of dabigatran etexilate for the prevention of venous thromboembolism in moderately renally impaired patients after total knee or hip replacement surgery / O.E. Dahl [et al.] // Blood. – 2008. – Vol. 112. – P. 361.
  6. Geerts, W.H. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy / W.H. Geerts [et al.] // Chest. – 2004. – Vol. 126. – Р. 338–400.
  7. Geerts, W.H. Prevention of venous thromboembolism: Evidence-Based Clinical Practice Guidelines (8th ed.) / W.H. Geerts [et al.] // Chest. – 2008. –Vol. 133. – Р. 381–453.
  8. Hill, J. Reducing the risk of venous thromboembolism in patients admitted to hospital: summary of the NICE guideline / J. Hill, T. Treasure // Heart. 2010. – Vol. 96, N 11. – P. 879–882.
  9. Huisman, M.V. Enoxaparin versus dabigatran or rivaroxaban for thromboprophylaxis after hip or knee arthroplasty results of separate pooled analyses of phase III multicenter randomized trials / M.V. Huisman, D. J. Quinlan, O. E. Dahl, S. Schulman // Cardiovasc. Qual. Outcomes. – 2010. – Vol. 3, N 6. – P. 652–660.
  10. Kujath, P. Incidence and prophylaxis of deep venous thrombosis in outpatients with injury of the lower limb/ P. Kujath, U. Spannagel, W. Habscheid // Haemostasis. – 1993. – Vol. 23, Suppl. 1. – P. 20–26.
  11. Kock, H.J. Thromboprophylaxis with low-molecularweight heparin in outpatients with plaster-cast immobilisation of the leg / H.J. Kock [et al.] // Lancet. – 1995. – N 346. – P.459–461
  12. Koch, A. Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis: meta-analysis based on original patient data / A. Koch, S. Ziegler, H. Breitschwerdt, N. Victor // Thromb. Res. – 2001. – Vol. 102. – P. 295 –309.
  13. Nurmohamed, M.T. Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis / M.T. Nurmohamed [et al.] // Lancet. – 1992. – Vol. 340. – Р. 152–156.
  14. Samama, C.M. Epidemiology of venous thromboembolism after lower limb arthroplasty: the FOTO study / C.M. Samama [et al.] // J. Thromb. Haemost. 2007. – Vol. 5, N 12. – P.2360 –2367.
  15. Selby, R. A prospective cohort study of the epidemiology of symptomatic thromboembolism (VTE) after isolated leg fractures distal to the knee without thromboprophylaxis / R. Selby [et al.] // Blood. – 2005. – Vol. 106. – P. 583.
  16. Schmida, P. Low-molecular-weight heparin in patients with renal insufficiency / P. Schmida, A. G. Fischerb, W. A. Wuillemina // Swiss. Med. Weekly. – 2009. – Vol. 139, N 31-32. – P. 438–452.
  17. Strebel, N. Preoperative or postoperative start of prophylaxis for venous thromboembolism with lowmolecular-weight heparin in elective hip surgery? / N. Strebel [et al.] // Arch. Intern. Med. – 2002. – Vol. 162. – P.1451–1456.
  18. Warwick, D. Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: findings from the Global Orthopaedic Registry / D. Warwick [et al.] / J. Bone Joint. Surg. – 2007. – Vol. 89-B. – Р. 799 –807.
  19. Wirth, T. Prevention of venous thromboembolism after knee arthroscopy with low-molecular weight heparin (reviparin): results of a randomized controlled trial / T. Wirth [et al.] // Arthroscopy. – 2001. – Vol. 17. – P. 393–399.

Copyright (c)



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies